NEXIEN BIOPHARMA, INC. Overview
Industry: Drug Manufacturers Specialty & Generic
Sector: Healthcare
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. The company is based in Glendale, Colorado.
NEXIEN BIOPHARMA, INC. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review NEXIEN BIOPHARMA, INC. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
NEXIEN BIOPHARMA, INC. Competitors
NEXIEN BIOPHARMA, INC. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans